Pubblicazioni

Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma  (2022)

Autori:
Dinoto, Alessandro; Mckeon, Andrew; Vattemi, Gaetano; Carta, Sara; Ferrari, Sergio; Mariotto, Sara
Titolo:
Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma
Anno:
2022
Tipologia prodotto:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Lingua:
Inglese
Formato:
Elettronico
Referee:
Nome rivista:
Journal of Neuroimmunology
ISSN Rivista:
0165-5728
N° Volume:
368
Numero o Fascicolo:
577882
Intervallo pagine:
1-3
Parole chiave:
Avelumab; Immune checkpoint inhibitors; Immune-related adverse events; Neuronal intermediate filament; Paraneoplastic neurological syndromes
Breve descrizione dei contenuti:
A 67-years-old woman developed subacute oculomotor nerve palsy and cerebellar gait instability while receiving avelumab as immunotherapy for Merkel cell carcinoma. Brain MRI revealed oculomotor nerve T2/FLAIR hyperintensity and contrast enhancement, CSF cell number and protein concentration were slightly increased. Antibodies against intracellular and surface antigens were excluded through commercial assays, but home-made immunohistochemistry on rat brain sections showed a "neurofilament-like" pattern. Antibodies against neuronal intermediate filament (NIF-IgG) were thus tested and resulted positive in both serum and CSF, confirming the diagnosis of NIF-IgG autoimmunity. Avelumab was discontinued and treatment with steroids and intravenous immunoglobulins led to partial improvement.
Pagina Web:
https://doi.org/10.1016/j.jneuroim.2022.577882
Id prodotto:
126872
Handle IRIS:
11562/1065104
ultima modifica:
26 giugno 2024
Citazione bibliografica:
Dinoto, Alessandro; Mckeon, Andrew; Vattemi, Gaetano; Carta, Sara; Ferrari, Sergio; Mariotto, Sara, Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma «Journal of Neuroimmunology» , vol. 368 , n. 5778822022pp. 1-3

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

<<indietro

Attività

Strutture

Condividi